Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss was found in 37.4% of surveyed rural high-school students in Eskisehir, Turkey, affecting their quality of life, especially in general health and mental well-being.

New cytokine-targeted therapies show promise for treating alopecia areata.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

Micrografts improve hair density and thickness without side effects.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Non-immune factors play a significant role in alopecia areata.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Mice with autoimmune hair loss showed signs of heart problems.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Low vitamin D levels are common in people with Alopecia Areata.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

A certain medication improved severe itching in a boy with liver and bowel disease by reducing histamine levels, suggesting a new treatment target.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Diphenylcyclopropenone is effective for treating alopecia areata but has a high relapse rate.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Combining oral methylprednisolone with microneedle radiofrequency improves hair growth in alopecia areata but may cause pain and side effects.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.